Skip to content
← Holders

Silverarc Capital Management, LLC

What Silverarc Capital Management, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1816307 · Filed Nov 12, 2026

Positions
70
Reported value
$854.4M
Opened
18
Closed
21
Other managers included
1

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$741.6M
    82 positions
  2. Dec 31, 2025$720.1M
    68 positions
  3. Mar 31, 2026$979.8M
    73 positions
  4. Jun 30, 2026$962.2M
    73 positions
  5. Sep 30, 2026$854.4M
    70 positions
SecuritySharesChangeValueOf portfolio
KODKodiak Sciences Inc.
750.2K+37.3%$71.1M8.3%
CELCCelcuity Inc.
803.2K+60.3%$63.9M7.5%
COGTCogent Biosciences, Inc.
1.6M+23.0%$50.4M5.9%
URGNUroGen Pharma Ltd.
1.1M−11.8%$46.7M5.5%
IMNMImmunome Inc.
2.1M+3.8%$45M5.3%
GLUEMonte Rosa Therapeutics, Inc.
3.1M+180.9%$37.1M4.3%
SGMTSagimet Biosciences Inc.
3.7M+28.0%$37M4.3%
ASNDAscendis Pharma A/S
152.2K−26.2%$34.7M4.1%
RYTMRhythm Pharmaceuticals, Inc.
348.3K+11.8%$33.2M3.9%
BIIBBiogen Inc.
112.8K+134.5%$25.5M3%
IMVTImmunovant, Inc.
624.1K+0.8%$21.1M2.5%
DNTHDianthus Therapeutics, Inc.
236.6K−39.3%$20.8M2.4%
ORKAOruka Therapeutics, Inc.
247.9K−29.7%$20.6M2.4%
ERASErasca, Inc.
1.3M+5.3%$19.5M2.3%
ABVXAbivax S.A.
175.7K+3.6%$17.4M2%
CLDXCelldex Therapeutics, Inc.
487.6KNew$15.8M1.8%
OVIDOvid Therapeutics Inc.
6M+91.9%$14.8M1.7%
SYRESpyre Therapeutics, Inc.
151.2K+152.1%$13.5M1.6%
DFTXDefinium Therapeutics, Inc.
345.9K−13.5%$13.2M1.5%
HLXCHelix Acquisition Corp. III
1.2M+2.6%$12.8M1.5%
ALKSAlkermes plc.
300.4K+164.7%$12.2M1.4%
CELLDEX THERAPEUTICS INC NEWCALLCall option
370.7KNew$12M1.4%
CCCCC4 Therapeutics, Inc.
3.5M+13.9%$11.5M1.3%
AVLNAvalyn Pharma Inc.
378.4K+14.5%$10.8M1.3%
ORIC PHARMACEUTICALS INCCALLCall option
702.4K+2.9%$9.5M1.1%
CERSCerus Corp
4M+13.8%$9.4M1.1%
ALXOALX Oncology Holdings Inc
6.6M+14.3%$9.1M1.1%
ZBIOZenas BioPharma, Inc.
334.1K−34.5%$9M1.1%
CMPSCOMPASS Pathways plc
717.4K+42.5%$8.9M1%
RNAQURainier Acquisition Corp
853.9KNew$8.7M1%
CGENCompugen Ltd
3.6M+12.6%$8.5M1%
SVRASavara Inc
1.5M+12.1%$7.8M0.9%
PCVXVaxcyte, Inc.
125.1K−13.7%$7.1M0.8%
YARWYarrow Bioscience, Inc.
301.9KNew$6.8M0.8%
IBIOiBio, Inc.
5.4M+52.2%$6.3M0.7%
ARCTArcturus Therapeutics Holdings Inc.
459.9KNew$6.3M0.7%
MONTE ROSA THERAPEUTICS INCCALLCall option
525K+75.0%$6.3M0.7%
PRAXPraxis Precision Medicines, Inc.
19.8K−69.9%$5.8M0.7%
KNSAKiniksa Pharmaceuticals International, plc
75.7KNew$5.6M0.7%
ELVNEnliven Therapeutics, Inc.
121.5K−75.2%$5.6M0.7%
SLDBSolid Biosciences Inc.
760.3K+13.7%$5.5M0.6%
EVMNEvommune, Inc.
594KNew$4.9M0.6%
SNDXSyndax Pharmaceuticals Inc
247.4K−79.6%$4.7M0.5%
BNTCBenitec Biopharma Inc.
443.1K−34.8%$4.4M0.5%
RACCResearch Alliance Corp III
404.7K+12.4%$4.4M0.5%
BLSMBlossomHill Therapeutics, Inc.
202.1KNew$3.8M0.4%
FTHFaeth Therapeutics, Inc.
124.1KNew$3.7M0.4%
ABEOAbeona Therapeutics Inc.
693.4K+13.6%$3.6M0.4%
RACDResearch Alliance Corp IV
302KNew$3.5M0.4%
ANLAdlai Nortye Group Ltd.
216.6KNew$3.5M0.4%
PALIPalisade Bio, Inc.
2.3MNew$3.2M0.4%
IRONDisc Medicine, Inc.
47.3K−42.9%$3.1M0.4%
ABSCI CORPORATIONPUTPut option
254.7K+61.6%$2.7M0.3%
TELATELA Bio, Inc.
2.1M±0%$2.5M0.3%
ZVRAZevra Therapeutics, Inc.
200.3KNew$2.2M0.3%
ORICOric Pharmaceuticals, Inc.
160.6K−78.3%$2.2M0.3%
CTNMContineum Therapeutics, Inc.
159K−46.3%$2.1M0.2%
MRNAModerna, Inc.
10KNew$1.9M0.2%
ELUTElutia Inc.
2.2M±0%$1.7M0.2%
FULCRUM THERAPEUTICS INCCALLCall option
391.9K±0%$1.5M0.2%
QUREuniQure N.V.
56.7K−46.0%$1.4M0.2%
ACHVAchieve Life Sciences, Inc.
159K−30.0%$1.3M0.2%
ACRSAclaris Therapeutics, Inc.
238.5K−87.7%$1.3M0.1%
RAPPRapport Therapeutics, Inc.
35.5KNew$1.2M0.1%
ZURA BIO LTDCALLCall option
242.2KNew$1M0.1%
CAMPCamp4 Therapeutics Corp
183.1K−72.0%$739.6K0.1%
ANNEXON INCCALLCall option
131.5KNew$556.2K0.1%
ZURAZura Bio Ltd
100KNew$416K0.1%
CLRBCellectar Biosciences, Inc.
151.1K−53.0%$278.1K0.1%
ADGMAdagio Medical Holdings, Inc.
170.5K−24.0%$26.1K0.1%